Vanguard Group Inc Dexcom Inc Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Dexcom Inc stock. As of the latest transaction made, Vanguard Group Inc holds 47,455,899 shares of DXCM stock, worth $4.07 Billion. This represents 0.06% of its overall portfolio holdings.
Number of Shares
47,455,899
Previous 46,530,017
1.99%
Holding current value
$4.07 Billion
Previous $3.62 Billion
10.44%
% of portfolio
0.06%
Previous 0.06%
Shares
17 transactions
Others Institutions Holding DXCM
# of Institutions
1,083Shares Held
362MCall Options Held
5.4MPut Options Held
4.3M-
Black Rock Inc. New York, NY34.5MShares$2.96 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.43 Billion0.05% of portfolio
-
Baillie Gifford & CO14.2MShares$1.22 Billion0.87% of portfolio
-
Capital Research Global Investors Los Angeles, CA12MShares$1.03 Billion0.19% of portfolio
-
Jennison Associates LLC10.5MShares$903 Million0.51% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $33.1B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...